Vnitr Lek 1993, 39(2):143-152

[Protective effect of Neoton during cardiovascular surgery. Hemodynamic and biochemical aspects].

R Záhorec, H Holomán, E Bilcíková, M Simo, R Tomlain, I Pechán
Ustav kardiovaskulárnych chorôb Bratislava.

The authors present the preliminary results of an experimental study where to a group of patients (n = 10) subjected to cardiosurgery, using extracorporeal circulation, to the cardioplegic solution creatine phosphate was added (Neoton of Alfa Schiaparelli Wasserman Co.)--2 g.l-1. The authors investigated haemodynamic and biochemical parameters and compared them on the day of operation with the same parameters assessed in a group of controls operated in the same way but without addition of creatine phosphate to the cardioplegic solution. Apart from insignificant differences in haemodynamic parameters the group of patients given Neoton had a lower malondialdehyde level during the early stage after termination of extracorporeal circulation, spontaneous defibrillation, a lower incidence of dysrhythmias and disorders of the conduction system. It can be assumed that creatine phosphate (Neoton) may be effective in the protection of the myocardium from ischaemia reperfusion damage.

Keywords: Adult; Aged; Cardiac Surgical Procedures; Cardioplegic Solutions; Hemodynamics, drug effects, ; Humans; Lactates, blood, ; Malondialdehyde, blood, ; Middle Aged; Oxygen Consumption, drug effects, ; Phosphocreatine, administration & dosage, ; Postoperative Complications

Published: February 1, 1993  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Záhorec R, Holomán H, Bilcíková E, Simo M, Tomlain R, Pechán I. [Protective effect of Neoton during cardiovascular surgery. Hemodynamic and biochemical aspects]. Vnitr Lek. 1993;39(2):143-152.
Download citation




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.